Phibro Animal Health (PAHC) Change in Accured Expenses (2013 - 2026)
Phibro Animal Health (PAHC) posted Change in Accured Expenses of $28.7 million for Q2 2026, up 7837.12% on a QoQ basis from $361000.0 in Q1 2026, and up 9.71% year-over-year from $26.1 million in Q2 2025.
Analysis
Phibro Animal Health (PAHC) Change in Accured Expenses (2013 - 2026) Analysis & Trends
Phibro Animal Health has reported Change in Accured Expenses for 14 years, with the latest figure at $28.7 million in Q2 2026.
- On a quarterly basis, Change in Accured Expenses rose 9.71% year-over-year to $28.7 million in Q2 2026; TTM through Jun 2026 was $26.4 million, a 44.12% decrease from a year earlier, with the FY2026 full-year figure at $26.4 million, down 44.12% from the prior year.
- Change in Accured Expenses was $28.7 million for Q2 2026 at Phibro Animal Health, up from $361000.0 in the prior quarter.
- The five-year high for Change in Accured Expenses was $28.7 million in Q2 2026, with the low at -$13.7 million in Q3 2025.
- Average Change in Accured Expenses over 5 years is $4.7 million, with a median of $445500.0 recorded in 2024.
- The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses surged 1357.99% in 2024, then sank 288.42% in 2025.
- Over 5 years, Change in Accured Expenses stood at $6.0 million in 2022, then soared by 36.38% to $8.2 million in 2023, then jumped by 202.8% to $24.8 million in 2024, then plunged by 55.48% to $11.0 million in 2025, then jumped by 159.89% to $28.7 million in 2026.
- The last three Change in Accured Expenses figures came in at $28.7 million (Q2 2026), $361000.0 (Q1 2026), and $11.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.69 Bn | 40.49 Bn | 779.09 Mn | - |
| 2 | Zoetis | 30.63 Bn | 28.95 Bn | 1.05 Bn | 142.00 Mn |
| 3 | Elanco Animal Health | 11.77 Bn | 11.24 Bn | 798.00 Mn | - |
| 4 | Phibro Animal Health | 1.49 Bn | 1.41 Bn | 134.40 Mn | 28.65 Mn |
| 5 | Immucell | 90.19 Mn | 81.33 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 76.23 Mn | 69.14 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.65 Mn |
| Mar 31, 2026 | 361,000.00 |
| Dec 31, 2025 | 11.03 Mn |
| Sep 30, 2025 | -13.69 Mn |
| Jun 30, 2025 | 26.12 Mn |
| Mar 31, 2025 | -199,000.00 |
| Dec 31, 2024 | 24.77 Mn |
| Sep 30, 2024 | -3.52 Mn |
| Jun 30, 2024 | 9.28 Mn |
| Mar 31, 2024 | 530,000.00 |
| Dec 31, 2023 | 8.18 Mn |
| Sep 30, 2023 | -5.80 Mn |
| Jun 30, 2023 | -738,000.00 |
| Mar 31, 2023 | -745,000.00 |
| Dec 31, 2022 | 6.00 Mn |
| Sep 30, 2022 | -10.26 Mn |
| Jun 30, 2022 | -591,000.00 |
| Mar 31, 2022 | 5.75 Mn |
| Dec 31, 2021 | 5.19 Mn |
| Sep 30, 2021 | -7.20 Mn |